Cargando…
New Approaches of PARP-1 Inhibitors in Human Lung Cancer Cells and Cancer Stem-Like Cells by Some Selected Anthraquinone-Derived Small Molecules
Poly (ADP-ribose) polymerase-1 (PARP-1) and telomerase, as well as DNA damage response pathways are targets for anticancer drug development, and specific inhibitors are currently under clinical investigation. The purpose of this work is to evaluate anticancer activities of anthraquinone-derived tric...
Autores principales: | Lee, Yu-Ru, Yu, Dah-Shyong, Liang, Ya-Chun, Huang, Kuo-Feng, Chou, Shih-Jie, Chen, Tsung-Chih, Lee, Chia-Chung, Chen, Chun-Liang, Chiou, Shih-Hwa, Huang, Hsu-Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581553/ https://www.ncbi.nlm.nih.gov/pubmed/23451039 http://dx.doi.org/10.1371/journal.pone.0056284 |
Ejemplares similares
-
A new niclosamide derivatives‐B17 can inhibit urological cancers growth through apoptosis‐related pathway
por: Wu, Chia‐Lun, et al.
Publicado: (2018) -
PARP1 controls KLF4-mediated telomerase expression in stem cells and cancer cells
por: Hsieh, Meng-Hsun, et al.
Publicado: (2017) -
Exosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells
por: Huang, Cheng-Shuo, et al.
Publicado: (2020) -
Unusual presentation of Castleman's disease mimicking lung cancer
por: Chen, Ming‐Tsung, et al.
Publicado: (2019) -
Naturally Occurring Anthraquinones: Chemistry and Therapeutic Potential in Autoimmune Diabetes
por: Chien, Shih-Chang, et al.
Publicado: (2015)